Dr. Penn and other senior VO-CRO staff members are available for consultation regarding:
- assessment of the current ocular drug development landscape
- current experimental standards for ocular drug development
- target identification
- target validation strategies
- experimental model selection
- experimental design
- IND portfolio development
- mechanism of action determination
- PK strategies
- formulation strategies
- toxicity determination strategies
- other topics
These services are included in the cost of research agreements, but are also available in the absence of a research agreement and are billed on an hourly basis. Please contact us to learn more about our consulting services and for pricing.
VO-CRO staff members are poised to train your personnel in cell- and animal-based study techniques to facilitate your discovery and drug development efforts. We have extensive expertise with cell-based models of growth factor and cytokine induction by disease-relevant stimuli and of induced cell behaviors relevant to ocular disease. We also have long-standing experience with animal models of ocular angiogenesis, vascular regression, vascular inflammation and neurodegeneration. Further information can be found under models. Your personnel may visit the VO-CRO laboratories for customized instruction in the use of these models. Please contact us to learn more about our training services and for pricing.